rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-9-6
|
pubmed:abstractText |
Recipient pulmonary hypertension due to chronic congestive heart failure is a major cause of right ventricular (RV) dysfunction after heart transplantation. We hypothesized that inhaled nitric oxide (NO), in the postoperative period, would a) selectively reduce pulmonary vascular resistance and improve RV hemodynamics and b) reduce the incidence of RV dysfunction compared with a matched historical group.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0041-1337
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
638-41
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11544423-Administration, Inhalation,
pubmed-meshheading:11544423-Adult,
pubmed-meshheading:11544423-Female,
pubmed-meshheading:11544423-Heart Failure,
pubmed-meshheading:11544423-Heart Transplantation,
pubmed-meshheading:11544423-Hemodynamics,
pubmed-meshheading:11544423-Humans,
pubmed-meshheading:11544423-Hypertension, Pulmonary,
pubmed-meshheading:11544423-Male,
pubmed-meshheading:11544423-Middle Aged,
pubmed-meshheading:11544423-Nitric Oxide,
pubmed-meshheading:11544423-Postoperative Care,
pubmed-meshheading:11544423-Prospective Studies,
pubmed-meshheading:11544423-Pulmonary Circulation,
pubmed-meshheading:11544423-Vascular Resistance,
pubmed-meshheading:11544423-Vasodilator Agents,
pubmed-meshheading:11544423-Ventricular Dysfunction, Right,
pubmed-meshheading:11544423-Ventricular Function, Right
|
pubmed:year |
2001
|
pubmed:articleTitle |
Inhaled nitric oxide for pulmonary hypertension after heart transplantation.
|
pubmed:affiliation |
Department of Surgery, UCLA Medical Center, Los Angeles 90095, USA. aardehali@mednet.ucla.edu
|
pubmed:publicationType |
Journal Article
|